Cargando…

Enrichment of Complement, Immunoglobulins, and Autoantibody Targets in the Proteome of Platelets from Patients with Systemic Lupus Erythematosus

Background  Systemic lupus erythematosus (SLE) is a complex disease characterized by autoimmunity toward apoptotic cells, excessive amounts of circulating immune complexes, and complement activation. A decreased platelet size has been observed in SLE and their nonhemostatic functions may play an act...

Descripción completa

Detalles Bibliográficos
Autores principales: Linge, Carl Petrus, Jern, Andreas, Tydén, Helena, Gullstrand, Birgitta, Yan, Hong, Welinder, Charlotte, Kahn, Robin, Jönsen, Andreas, Semple, John W., Bengtsson, Anders A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420555/
https://www.ncbi.nlm.nih.gov/pubmed/35419777
http://dx.doi.org/10.1055/a-1825-2915
_version_ 1784777416593375232
author Linge, Carl Petrus
Jern, Andreas
Tydén, Helena
Gullstrand, Birgitta
Yan, Hong
Welinder, Charlotte
Kahn, Robin
Jönsen, Andreas
Semple, John W.
Bengtsson, Anders A.
author_facet Linge, Carl Petrus
Jern, Andreas
Tydén, Helena
Gullstrand, Birgitta
Yan, Hong
Welinder, Charlotte
Kahn, Robin
Jönsen, Andreas
Semple, John W.
Bengtsson, Anders A.
author_sort Linge, Carl Petrus
collection PubMed
description Background  Systemic lupus erythematosus (SLE) is a complex disease characterized by autoimmunity toward apoptotic cells, excessive amounts of circulating immune complexes, and complement activation. A decreased platelet size has been observed in SLE and their nonhemostatic functions may play an active role in the disease. The main objective of this study was to find clues that could explain their decreased size and functional role, analyzing the entire platelet proteome. Methods  Platelets were isolated from 23 patients with SLE. The five individuals with the highest and lowest average platelet forward scatter were selected for further analysis. Platelet protein content was analyzed using liquid chromatography with tandem mass spectrometry (LC-MS/MS) and compared with platelets from five healthy controls. Data are available via ProteomeXchange with identifier PXD031202. Results  Out of 2,572 proteins identified, 396 had significantly different levels (ANOVA q -value ≤ 0.01). Forty proteins, including immunoglobulin-, complement- and phosphatidylserine-binding proteins had higher abundance in platelets from SLE patients, largely independent of size (fold difference of ≥1.5 and a t -test p -value of ≤0.05 as cut-off). Functional characterization revealed increased degranulation and skewed hemostatic balance in platelets from SLE patients. In the SLE proteome, immunoglobulin proteins were negatively correlated to serum complement C3 and C4 and the highest relative levels were detected in platelets of normal size. Conclusion  Platelets from SLE patients shared a specific protein profile, including immunoglobulins, complement proteins, and autoantigens, largely independent of the platelet size and in agreement with an integrated role for platelets in SLE.
format Online
Article
Text
id pubmed-9420555
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-94205552022-08-29 Enrichment of Complement, Immunoglobulins, and Autoantibody Targets in the Proteome of Platelets from Patients with Systemic Lupus Erythematosus Linge, Carl Petrus Jern, Andreas Tydén, Helena Gullstrand, Birgitta Yan, Hong Welinder, Charlotte Kahn, Robin Jönsen, Andreas Semple, John W. Bengtsson, Anders A. Thromb Haemost Background  Systemic lupus erythematosus (SLE) is a complex disease characterized by autoimmunity toward apoptotic cells, excessive amounts of circulating immune complexes, and complement activation. A decreased platelet size has been observed in SLE and their nonhemostatic functions may play an active role in the disease. The main objective of this study was to find clues that could explain their decreased size and functional role, analyzing the entire platelet proteome. Methods  Platelets were isolated from 23 patients with SLE. The five individuals with the highest and lowest average platelet forward scatter were selected for further analysis. Platelet protein content was analyzed using liquid chromatography with tandem mass spectrometry (LC-MS/MS) and compared with platelets from five healthy controls. Data are available via ProteomeXchange with identifier PXD031202. Results  Out of 2,572 proteins identified, 396 had significantly different levels (ANOVA q -value ≤ 0.01). Forty proteins, including immunoglobulin-, complement- and phosphatidylserine-binding proteins had higher abundance in platelets from SLE patients, largely independent of size (fold difference of ≥1.5 and a t -test p -value of ≤0.05 as cut-off). Functional characterization revealed increased degranulation and skewed hemostatic balance in platelets from SLE patients. In the SLE proteome, immunoglobulin proteins were negatively correlated to serum complement C3 and C4 and the highest relative levels were detected in platelets of normal size. Conclusion  Platelets from SLE patients shared a specific protein profile, including immunoglobulins, complement proteins, and autoantigens, largely independent of the platelet size and in agreement with an integrated role for platelets in SLE. Georg Thieme Verlag KG 2022-07-24 /pmc/articles/PMC9420555/ /pubmed/35419777 http://dx.doi.org/10.1055/a-1825-2915 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Linge, Carl Petrus
Jern, Andreas
Tydén, Helena
Gullstrand, Birgitta
Yan, Hong
Welinder, Charlotte
Kahn, Robin
Jönsen, Andreas
Semple, John W.
Bengtsson, Anders A.
Enrichment of Complement, Immunoglobulins, and Autoantibody Targets in the Proteome of Platelets from Patients with Systemic Lupus Erythematosus
title Enrichment of Complement, Immunoglobulins, and Autoantibody Targets in the Proteome of Platelets from Patients with Systemic Lupus Erythematosus
title_full Enrichment of Complement, Immunoglobulins, and Autoantibody Targets in the Proteome of Platelets from Patients with Systemic Lupus Erythematosus
title_fullStr Enrichment of Complement, Immunoglobulins, and Autoantibody Targets in the Proteome of Platelets from Patients with Systemic Lupus Erythematosus
title_full_unstemmed Enrichment of Complement, Immunoglobulins, and Autoantibody Targets in the Proteome of Platelets from Patients with Systemic Lupus Erythematosus
title_short Enrichment of Complement, Immunoglobulins, and Autoantibody Targets in the Proteome of Platelets from Patients with Systemic Lupus Erythematosus
title_sort enrichment of complement, immunoglobulins, and autoantibody targets in the proteome of platelets from patients with systemic lupus erythematosus
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420555/
https://www.ncbi.nlm.nih.gov/pubmed/35419777
http://dx.doi.org/10.1055/a-1825-2915
work_keys_str_mv AT lingecarlpetrus enrichmentofcomplementimmunoglobulinsandautoantibodytargetsintheproteomeofplateletsfrompatientswithsystemiclupuserythematosus
AT jernandreas enrichmentofcomplementimmunoglobulinsandautoantibodytargetsintheproteomeofplateletsfrompatientswithsystemiclupuserythematosus
AT tydenhelena enrichmentofcomplementimmunoglobulinsandautoantibodytargetsintheproteomeofplateletsfrompatientswithsystemiclupuserythematosus
AT gullstrandbirgitta enrichmentofcomplementimmunoglobulinsandautoantibodytargetsintheproteomeofplateletsfrompatientswithsystemiclupuserythematosus
AT yanhong enrichmentofcomplementimmunoglobulinsandautoantibodytargetsintheproteomeofplateletsfrompatientswithsystemiclupuserythematosus
AT welindercharlotte enrichmentofcomplementimmunoglobulinsandautoantibodytargetsintheproteomeofplateletsfrompatientswithsystemiclupuserythematosus
AT kahnrobin enrichmentofcomplementimmunoglobulinsandautoantibodytargetsintheproteomeofplateletsfrompatientswithsystemiclupuserythematosus
AT jonsenandreas enrichmentofcomplementimmunoglobulinsandautoantibodytargetsintheproteomeofplateletsfrompatientswithsystemiclupuserythematosus
AT semplejohnw enrichmentofcomplementimmunoglobulinsandautoantibodytargetsintheproteomeofplateletsfrompatientswithsystemiclupuserythematosus
AT bengtssonandersa enrichmentofcomplementimmunoglobulinsandautoantibodytargetsintheproteomeofplateletsfrompatientswithsystemiclupuserythematosus